Navigation Links
Newborn screening program aims to help transform treatments for genetic diseases detected at birth
Date:1/17/2012

Within the first days of life, screening tests are performed on all newborns born in the U.S. to identify rare and often life-threatening medical conditions that are not apparent at birth. These newborn screening programs have been operating for decades, permitting doctors to intervene early and improve outcomes in potentially devastating conditions.

Now a pediatric research project plans to strategically expand the data collection linked to newborn screening results, aiming to open up broad opportunities to develop new ways to screen for and treat childhood diseases.

Many existing therapies for rare childhood diseases are seriously limited, while screening tests and treatments remain to be discovered for many other congenital disorders not currently included in newborn screening. At The Children's Hospital of Philadelphia, a research group is developing tools to store long-term clinical data on children with conditions picked up in the screening tests. The goal is to harness the power of numbersusing clinical data from many patients over years of their lives as a resource for researchers seeking new and better tests and treatments.

As biomedical knowledge and screening technology advance, more disorders have been added to those included in newborn screening, and the list will continue to grow.

"Currently, newborn screening programs are primarily limited to a short-term focus," said project leader Peter S. White, M.D., director of the Center for Biomedical Informatics (CBMi) at The Children's Hospital of Philadelphia. "The programs screen for disorders in which early intervention is possible. If we can broaden the data capture to follow up children over a longer term, we can tap the potential to develop new medical tests and interventions for diseases that are not currently detectable or treatable."

Awarded this past October, the CBMi's project, the Long-Term Follow-Up Data Collection Tool, is part of an ongoing five-year award from the Newborn Screening Translational Research Network (NBSTRN) to the American College of Medical Genetics. The NBSTRN, in turn, is funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development, part of the National Institutes of Health.

The subcontract award to Children's Hospital totals $1.8 million over three years.

A classic example of a disease detected in newborn screening is phenylketonuria (PKU), in which a mutated gene disables a patient's ability to process the amino acid phenylananine. Untreated, the excess amino acid causes severe mental retardation. But major diet restrictions, beginning in the first few weeks of life, allow near-normal development. Newborn screening programs have sharply reduced PKU-related mental retardation over the past four decades.

Over the years, more than 50 additional diseases have been added to the newborn screening list, including sickle cell disease and cystic fibrosis. If the initial screening flags a suspected disorder, healthcare providers order further tests to confirm or rule out the first result.

The data repository planned in this project will store long-term clinical records of patients who test positive for a disorder in the confirmatory test. Secure, centralized records will collect results of follow-up tests, disease complications, medications and treatment records over the years. To protect confidentiality, the clinical information will not include patient identities--but will provide invaluable clues to authorized researchers seeking to improve disease outcomes.

"Genetic diseases don't go away; a big question is what happens after the newborn period," said Michael J. Bennett, Ph.D., director of the Metabolic Disease Laboratory at Children's Hospital, who chaired a group in the National Academy of Clinical Biochemistry that developed national guidelines for follow-up testing of metabolic diseases detected in newborn screening. "Collecting data will allow researchers to monitor long-term outcomes and develop better strategies to diagnose and treat diseases."

A centralized database will allow scientists to detect patterns in the data that typically would not be discernible among the small number of cases followed in any single center. "Researchers will be better able to determine which treatments may yield better outcomes," Bennett said, adding that knowledge of genetic profiles may also allow investigators to modify treatment based on genetic background. Such treatments may include new gene therapies, enzyme replacement strategies, or developing drugs to act on targeted metabolic pathways.

White said that longer-term follow-up information in the repository may provide the potential to develop interventions for currently untreatable diseases, for example, spinal muscular atrophy, a complex and devastating neurological disorder that can be detected at birth, though not currently on the list of diseases included in newborn screening. "We envision that this data collective could become a transformative resource for biomedical research," he added.


'/>"/>

Contact: John Ascenzi
Ascenzi@email.chop.edu
267-426-6055
Children's Hospital of Philadelphia
Source:Eurekalert

Related medicine news :

1. New Research Shows 'Kangaroo Mother Care' Reduces Newborn Deaths More than 50 Percent
2. Expectant Moms Exercise Keeps Newborns Birth Weight Down
3. Dying: Millions of women in childbirth, newborns and young children
4. Newborn infants learn while asleep; study may lead to later disability tests
5. New blood test for newborns to detect allergy risk
6. Technology Innovation Advances Newborn Screen Translational Research Network
7. Could waiting 2 minutes improve how newborns recover from heart surgery?
8. Experts recommend universal screening of newborns for congenital adrenal hyperplasia
9. Newborn Hearing Tests More Effective Than Later Screening
10. Tiniest Newborns With Down Syndrome Face Other Health Risks
11. Fighting flu in newborns begins in pregnancy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2017)... GREENVILLE, SC (PRWEB) , ... January 23, 2017 ... ... which is the premiere organization in North America for the scientific development, healthcare ... its 2017 Annual Scientific Session, and its 2017 AAT Member Certification Qualification Courses ...
(Date:1/23/2017)... ... January 23, 2017 , ... Steviva Ingredients, makers of all-natural ... USDA National Organic Program (NOP) for its Portland SQF Level 2 manufacturing facility. ... and handling systems to complement our current rigorous food-safety management systems,” said Yishu ...
(Date:1/23/2017)... ... January 23, 2017 , ... ... general gynecological care and gynecological services for women of all ages. ... for a wide variety of reproductive services from routine health screenings to diagnosing ...
(Date:1/23/2017)... ... ... “Life Under Blankets”: an entrancing story about one woman's travels through the ... creation of published author, Kimberly Mitchell, who earned her bachelor’s degree in English education ... a master’s degree in education in the field of curriculum and instruction. Kimberly’s passion ...
(Date:1/22/2017)... Boca Raton, FL (PRWEB) , ... January 22, 2017 , ... ... products to customers across the world, recently met with big-name retail buyers at the ... strong scientific evidence of efficacy and uses the utmost safety standards in all of ...
Breaking Medicine News(10 mins):
(Date:1/23/2017)... N.Y. , Jan. 23, 2017 LifeVac, ... from a blocked airway and prevented choking deaths, welcomes ... awareness advocate to the LifeVac team as Official Spokesperson. ... Steve join the LifeVac team," said Arthur Lih ... positioned to represent LifeVac and his mission to raise ...
(Date:1/23/2017)... , Jan 23, 2017 Research and Markets has ... & Trends - Product - Forecast to 2025" report to their ... Report Highlights: ... future market trends to identify the investment opportunities Market ... Key market trends across the business segments, Regions and Countries ...
(Date:1/23/2017)... January 23, 2017 Stock-Callers.com today presents ... (NASDAQ: CPRX ), Sophiris Bio Inc. (NASDAQ: ... ), and Agile Therapeutics Inc. (NASDAQ: AGRX ). ... somewhat lower in late trade on Friday, January 20 th ... 0.3%, while shares of health care companies in the S&P ...
Breaking Medicine Technology: